Our Science

Filter Science by Keyword

Filter science by  modality  Clear filters

Publication
Mathematical Modeling and the Monkey King: Use of modeling for more efficient NHP study design
Disease Area
  • Multiple
Modality
  • Multiple
View Details
Publication
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions
Disease Area
  • Multiple
Modality
  • Multiple
View Details
Publication
Getting the Dose Right in Oncology
By: Dr. Alison Betts, Vice President of Scientific Collaborations and Fellow of Modeling & Simulation of Applied BioMath
Disease Area
  • Oncology
  • Immuno-oncology
Modality
  • Multiple
View Details
Collaboration
Poster
Dose Selection for DuoBody®-PD-L1x4-1BB (GEN1046) Using a Semimechanistic Pharmacokinetics/Pharmacodynamics Model That Leverages Preclinical and Clinical Data
Collaboration with Genmab - Presented at SITC 2021
Disease Area
  • Immuno-oncology
Modality
  • Bispecific
View Details
Collaboration
Poster
A computational semi-mechanistic pharmacology model of ATG-101, a PD-L1/4-1BB bispecific antibody for treatment of solid tumors
Collaboration with Antengene - Presented at SITC 2021
Disease Area
  • Oncology
Modality
  • Bispecific
View Details
Publication
Mathematical Approaches for Predicting Risks Early-On in Drug R&D
Published in Pharma Tech Outlook Magazine
Disease Area
  • Multiple
Modality
  • Bispecific
  • mAb
View Details
Publication
Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology
Published in Clinical Pharmacology & Therapeutics
Disease Area
  • Oncology
Modality
  • Bispecific
View Details
Collaboration
Webinar
Translational Modeling Strategies to Predict Clinical Doses for CD3 Bispecific Molecules
Collaboration with Pfizer - Presented by Alison Betts, Applied BioMath
Disease Area
  • Oncology
Modality
  • Bispecific
View Details
Collaboration
Webinar
QSP Modeling for Dual Targeting Approaches for Two Immuno-oncology Therapeutics
Collaboration with Jounce - Presented by Dr. John M. Burke, Applied BioMath
Disease Area
  • Immuno-oncology
Modality
  • Bispecific
View Details
Publication
Mechanistic PKPD Models of Protein Therapeutics for Early Clinical Development
Published in AAPS Newsmagazine
Disease Area
  • Multiple
Modality
  • Multiple
View Details
Collaboration
Poster
QSP Approaches Accelerate a PD-1 x TIM-3 Therapeutic in Immuno-oncology
Collaboration with Jounce
Disease Area
  • Immuno-oncology
Modality
  • Bispecific
View Details
Collaboration
Poster
Non-clinical Studies to Clinical Design Using QSP Model of T Cell Engaging Bispecifics
Collaboration with Pfizer - Presented at AAPS 2019 PharmSci 360
Disease Area
  • Oncology
Modality
  • Bispecific
View Details